Vimarsana
Biggest News Aggregation in the World

Page 45 - Thomas Triomphe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Triomphe Today - Breaking & Trending Today

Sanofi-GSK reports success in Covid-19 vaccine, after setback - Vimarsana News

Sanofi-GSK reports success in Covid-19 vaccine, after setback

Sanofi-GSK reports success in Covid-19 vaccine, after setback SECTIONS Last Updated: May 17, 2021, 01:45 PM IST Share Synopsis The drugmakers said they plan to begin late-stage trials and production in the coming weeks and hope to win regulatory approval for the vaccine before the end of 2021. AFP GlaxoSmithKline's potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year. After two doses of the vaccine candidate, participants showed neutralis...

Coronavirus: Sanofi-GSK reports success in vaccine, after setback - Vimarsana News

Coronavirus: Sanofi-GSK reports success in vaccine, after setback

  PARIS -- Sanofi and GlaxoSmithKline's potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year. After two doses of the vaccine candidate, participants showed neutralizing antibodies in line with those found in people who had recovered from the disease, according to results of the Phase 2 trial released Monday. The drugmakers said they plan to begin late-stage trials and production in the coming weeks and hope to win regulatory approval ...

Source: ctvnews.ca
Sanofi, GSK say Covid vaccine shows positive result | World - Vimarsana News

Sanofi, GSK say Covid vaccine shows positive result | World

Monday, 17 May 2021 03:17 PM MYT The Sanofi logo is seen at the company's Sanofi Pasteur headquarters in Lyon, France, October 26, 2015. — Reuters pic Subscribe to our Telegram channel for the latest updates on news you need to know. PARIS, May 17 — French pharmaceuticals giant Sanofi and Britain’s GSK reported on Monday “strong immune responses” in early tests of their Covid-19 vaccine, raising hopes it could join the fight against the pandemic. The companies said the results of the Phase 2 study will enable them to move to a late-stage trial in the coming weeks — a reversal of f...

GSK and Sanofi hope to have Covid vaccine ready this year - Vimarsana News

GSK and Sanofi hope to have Covid vaccine ready this year

Glaxo hopes to have its Covid-19 vaccine ready by end of year as trials progress DRUGS manufacturer Glaxo is ready to move onto the next stage of its Covid-19 vaccine trial as it looks to have it in use by the end of the year. GlaxoSmithKline, which has a site in Barnard Castle, and Sanofi’s Covid-19 vaccine saw strong results from its phase 2 trial and will now move on to a larger phase 3 trial as the drugs firms try to catch up with the competition. Interim results from the study show a 95 per cent to 100 per cent seroconversion following a second injection in patients from ages 1...

Sanofi-GSK COVID vaccine strongly protects adults in trials - Vimarsana News

Sanofi-GSK COVID vaccine strongly protects adults in trials

PARIS — Sanofi and GlaxoSmithKline’s potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials, boosting hope that the shot could join the fight against the pandemic this year. After two doses of the vaccine candidate, participants showed neutralizing antibodies in line with those found in people who had recovered from the disease, according to results of the Phase 2 trial released Monday. The drugmakers said they plan to begin late-stage trials and production in the coming weeks and hope to win regulatory approval for the vaccine before t...